Five types of X chromosomes with different amounts of heterochromatin have been observed in Nesokia indica, the Indian mole rat. They have been found in both mosaic and non-mosaic individuals. The influence, if any, of heterochromatin on the kinetics of X-chromosome DNA replication was evaluated in bone marrow cells and peripheral blood lymphocytes of Nesokia females with variant X chromosomes. In bone marrow cells of nonmosaic females a random X-chromosome inactivation (XCI) pattern was observed, except when there was a total loss of heterochromatin from the variant X chromosome, resulting in predominantly early replication. A nonrandom pattern was observed, however, in blood and bone marrow cells of all individuals with mosaic genotypes. In these females the X chromosome with the lesser amount of heterochromatin was predominantly the active one. The amount of heterochromatin per se or, more likely, specific sequences contained in the heterochromatic region seem to influence the XCI pattern in a cis-acting manner. The observations also seem to support a process of cell selection in individuals with variant X chromosomes.

This content is only available via PDF.
© 1991 S. Karger AG, Basel
1991
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.